Im folgenden finden Sie eine Auswahl von Publikationen über PentraSorb® CRP und zur pathologischen Wirkung von CRP thematisch sortiert.
Kardiovaskulär
- Current Pharmaceutical Design 2023; 8, doi: 10.2174/1381612829666230310090601.
C-reactive Protein Apheresis in Acute Myocardial Infarction Study
Milosevic M, Balint B, Ilic I, Dukuljev N, Otasevic P. - J. Clin. Med. 2022; 11, 6446. doi: 10.3390/jcm11216446.
Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction—Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study
Skarabis H, Torzewski J, Ries W, Heigl F, Garlichs C.D, Kunze R, Sheriff A. - J. Clin. Med. 2022; 11(4), 1058. doi: 10.3390/jcm11041058.
C-Reactive Protein (CRP) Blocks the Desensitization of Agonistic Stimulated G Protein Coupled Receptors (GPCRs) in Neonatal Rat Cardiomyocytes.
Wallukat G, Mattecka S, Wenzel K, Schrödl W, Vogt B, Brunner P, Sheriff A, Kunze R.
- Intensiv News. Ausgabe 3/2021; Jahrgang 25: 14-17.
CRP-Apherese bei Herzinfarkt – eine Therapieoption?.
Werdan K.
Veröffentlichung mit freundlicher Genehmigung der Medicom VerlagsgmbH
- Nephro News. Ausgabe 2/2021; Jahrgang 23: 23-26.
CRP-Apherese beim Myokardinfarkt: Eine neue Domäne der Nephrologie?.
Gauckler P, Mayer G.
Veröffentlichung mit freundlicher Genehmigung der Medicom VerlagsgmbH
- Front Cardiovasc Med. 2021 Mar 8:591714. doi: 10.3389/fcvm.2021.591714.
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study
Ries W, Torzweski J, Heigl F, Pfluecke C, Kelle S, Darius H, Ince H, Mitzner S, Nordbeck P, Butter C, Skarabis H, Sheriff A, Garlichs CD, on behalf of the CAMI-1 Investigators.
- Int J Cardiol. 2020 Dec 9;328:191-196. doi: 10.1016/j.ijcard.2020.12.006.
High sensitivity C-reactive protein is associated with worse infarct healing after revascularized ST-elevation myocardial infarction.
Tiller C, Reindl M, Holzknecht M, Lechner I, Simma F, Schwaiger J, Mayr A, Klug G, Bauer A, Reinstadler SJ, Metzler B.
- Blood Purif. 2020 Feb 28:1-5. doi: 10.1159/000506176.
A Promising Innovative Treatment for ST-Elevation Myocardial Infarction: The Use of C-Reactive Protein Selective Apheresis: Case Report
Boljevic D, Nikolic A, Rusovic S, Lakcevic J, Bojic M, Balint B.
- Ther Apher Dial. 2019 Dec;23(6):570-574. doi: 10.1111/1744-9987.12804. Epub 2019 Apr 29.
Selective C-Reactive Protein-Apheresis in Patients.
Ries W, Heigl F, Garlichs C, Sheriff A, Torzewski J.
- Nephro News. Ausgabe 6/2019; Jahrgang 21: 23-27.
Die CRP-Apherese: Eine neue Therapiemöglichkeit bei Inflammation.
Ries W.
Veröffentlichung mit freundlicher Genehmigung der Medicom VerlagsgmbH
- Case Rep Cardiol. 2018 Nov 6;2018:4767105. doi: 10.1155/2018/4767105. eCollection 2018.
“First in Man”: Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction.
Ries W, Sheriff A, Heigl F, Zimmermann O, Garlichs CD, Torzewski J.
- Clin Cardiol. 2018 Jun 27;41(9):1201-1206. doi: 10.1002/clc.23017.
C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up.
Vanhaverbeke M, Veltman D., Pattyn N, De Crem N, Gillijns H, Cornelissen V, Janssens S, Sinnaeve PR.
- Europ Heart J. 2017 Oct 1;6(7):640–649. doi: 10.1177/2048872616661691.
Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
Reindl M, Reinstadler SJ, Feistritzer H, Klug G, Tiller C, Mair J, Mayr A, Jaschke W, Metzler B.
- Arch Med Sci. 2017 Aug;13(5):1086-1093. doi: 10.5114/aoms.2017.69327. Epub 2017 Aug 3.
C-reactive protein levels predict systolic heart failure and outcome in patients with first ST-elevation myocardial infarction treated with coronary angioplasty.
Stumpf C, Sheriff A, Zimmermann S, Schaefauer L, Schlundt C, Raaz D, Garlichs CD, Achenbach S.
- BMC Cardiovasc Disord. 2016 Nov 28;16(239). doi: 10.1186/s12872-016-0415-z.
Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
Feistritzer H, Reinstadler SJ, Klug G, Reindl M, Wöhrer S, Brenner C, Mayr A, Mair J, Metzler B.
- J Clin Apher. 2015 Feb;30(1):15-21. doi: 10.1002/jca.21344. Epub 2014 Jul 5.
Selective apheresis of C-reactive protein: a new therapeutic option in myocardial infarction?
Sheriff A, Schindler R, Vogt B, Abdel-Aty H, Unger JK, Bock C, Gebauer F, Slagman A, Jerichow T, Mans D, Yapici G, Janelt G, Schröder M, Kunze R, Möckel M.
- Blood Purif. 2011;31(1-3):9-17. doi: 10.1159/000320763. Epub 2010 Dec 7.
Specific removal of C-reactive protein by apheresis in a porcine cardiac infarction model.
Slagman AC, Bock C, Abdel-Aty H, Vogt B, Gebauer F, Janelt G, Wohlgemuth F, Morgenstern R, Yapici G, Puppe A, Modersohn D, Mans D, Jerichow T, Ott S, Kunze R, Schrödl W, Janko C, Hermann M, Kalden JR, Kern P, Parsch H, Kirschfink M, Schulz-Menger J, Röttgen R, Unger JK, Frei U, Schindler R, Möckel M, Sheriff A.
- N Engl J Med. 2006 Aug 3;355(5):513-5.
Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein.
Kitsis RN, Jialal I. - Nature. 2006 Apr 27;440(7088):1217-21.
Targeting C-reactive protein for the treatment of cardiovascular disease.
Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, Hawkins PN, Myers RM, Smith MD, Polara A, Cobb AJ, Ley SV, Aquilina JA, Robinson CV, Sharif I, Gray GA, Sabin CA, Jenvey MC, Kolstoe SE, Thompson D, Wood SP.
- J Pharmacol Exp Ther. 2002 Dec;303(3):1007-13.
C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion.
Barrett TD, Hennan JK, Marks RM, Lucchesi BR.
- J Exp Med. 1999 Dec 20;190(12):1733-40.
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.
Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, Pepys MB.